Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion type Assertion NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_head.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion description "[Overexpression of p53, normally secondary to gene mutation, in invasive uroepithelial neoplasms (transitional cell carcinoma) and a high percentage of transitional cell carcinoma in situ (CIS) has been described; however, the role of p53 before and after bacillus Calmette-Gu�rin (BCG) treatment of CIS needs to be defined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_provenance.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion evidence source_evidence_literature NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_provenance.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion SIO_000772 9111623 NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_provenance.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion wasDerivedFrom befree-2016 NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_provenance.
- NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_assertion wasGeneratedBy ECO_0000203 NP1371018.RAOigQFaDL4Rj2vvr7hZxC72SXCcaglnRV-u_2PBMpLpM130_provenance.